A case in point: it turns out that only about half of the new prescription medications pushed onto the market over the last decade had the proper data together for the U.S. Food and Drug Administration - yet the FDA approved them anyhow.
The researchers found that only about half of 197 eligible approved NMEs between 2000 and 2010 had comparative efficacy data available at the time they were approved to be marketed.
Meanwhile, another recent study throws needed light on the limited data behind the safety and effectiveness of some Big Pharma drugs.
When abortion restrictions are in the news, as they have been for several weeks, research shows...
Yet another item that may be in your pantry has been recalled over possible salmonella contamination.
A...
By the time the American surgeon who contracted Ebola in Congo was flown to Germany for...
The Trump administration has announced a plan to kill Biden-era drinking water limits on four Pfas...
